Events

Pharma/medtech products cannot be successful without a favourable cost-effectiveness and budget impact profile. Upon completion of this course, you will master the fundamentals of health economic evaluations as a non-health-economist, and add value to decisions and communications related to products in R&D and/or brands in the market.

This course, led by two of Europe’s most respected forecasting experts in pharma, will teach you the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals.

This course, led by two of Europe’s most respected forecasting experts in pharma, will teach you the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals.

For many pharma companies, the most significant source of new products lies in Business Development. Often, the business development function falls short due to a lack of strategic alignment and a failure to coordinate efforts across the organisation. To optimise successful transactions and partnerships, companies need a structured business development and licensing process, and all contributors need to understand the whole process. This course offers a unique opportunity to speed up your learning curve by giving you a comprehensive overview of the licensing process in the context of business development in the pharma-biotech world.

Most countries have their own Health Technology Assessment (HTA) body with specific views about which criteria to be used and how the HTA process should be conducted. On top of that, EU-level networks strive for a more efficient use of resources and increased collaboration between all stakeholders involved. In this 1-day course you will learn how companies should optimise processes and criteria in this complex environment.

This course will equip you with the knowledge and tools to engage effectively with the right key opinion leaders at the right time in a product’s lifecycle, ensuring the strategic needs of your products are met, as set out in the Medical/Brand Plan.

In this course you will get many tips and tricks on how to choose the most effective tactics to reach the goals set in the Medical Plan, and on how to optimally plan and execute them throughout the year. Participate in this course for the unique opportunity to gain advice for your specific questions from a true Medical Affairs expert. Join a group of your international cross-industry peers, mostly medical advisors and medical science liaisons, to learn from their experiences, discuss common issues and gain new ideas.

This one-day programme empowers Commercial and Medical Affairs managers to become highly effective contributors to the cross-functional process required for a successful omnichannel pharma brand launch.

This one-day programme empowers Commercial and Medical Affairs managers to become highly effective contributors to the cross-functional process required for a successful omnichannel pharma brand launch.

In the high-stakes world of biotechnology and pharmaceuticals, traditional valuation methods fall short. The industry presents unique challenges that require specialised expertise: High R&D Attrition Rates, Extended Investment Cycles and Complex IP Landscapes. This hands-on introductory course equips you with practical valuation tools essential for Financing rounds and investment decisions, Mergers & Acquisitions (M&A), Licensing deals and partnerships, Strategic development planning, Portfolio optimisation.

This two-day programme equips you with important concepts, tools, and techniques that increase the impact of the Medical Affairs role, be it as a manager of teams or as a key contributor in cross-functional teams.

The goal of this course is to demystify market access for anyone involved. By participating, you will not only have the chance to ask your specific questions of a true expert, but also experience the unique opportunity to share experiences and engage in in-depth discussions with your international peers. Additionally, you will be equipped with clear schematic overviews of the market access systems in Europe’s major markets as a resource for reference in your daily work.